DE

464

+1.45%↑

CTAS

209.63

+0.81%↑

CPRT

61.97

+1.39%↑

CSX

28.11

+1.85%↑

PAYX

144.32

+0.85%↑

DE

464

+1.45%↑

CTAS

209.63

+0.81%↑

CPRT

61.97

+1.39%↑

CSX

28.11

+1.85%↑

PAYX

144.32

+0.85%↑

DE

464

+1.45%↑

CTAS

209.63

+0.81%↑

CPRT

61.97

+1.39%↑

CSX

28.11

+1.85%↑

PAYX

144.32

+0.85%↑

DE

464

+1.45%↑

CTAS

209.63

+0.81%↑

CPRT

61.97

+1.39%↑

CSX

28.11

+1.85%↑

PAYX

144.32

+0.85%↑

DE

464

+1.45%↑

CTAS

209.63

+0.81%↑

CPRT

61.97

+1.39%↑

CSX

28.11

+1.85%↑

PAYX

144.32

+0.85%↑

Search

Enovis Corp

Closed

SectorIndustrials

35.07 3.7

Overview

Share price change

24h

Current

Min

33.55

Max

35.32

Key metrics

By Trading Economics

Income

-672M

-703M

Sales

56M

561M

EPS

0.98

Profit margin

-125.353

Employees

7,367

EBITDA

-602M

-590M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+85.59% upside

Dividends

By Dow Jones

Next Earnings

8 maj 2025

Market Stats

By TradingEconomics

Market Cap

-782M

1.8B

Previous open

31.37

Previous close

35.07

Enovis Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 sty 2025, 23:28 UTC

Major Market Movers

Maplebear Up on S&P MidCap 400 Inclusion

Peer Comparison

Price change

Enovis Corp Forecast

Price Target

By TipRanks

85.59% upside

12 Months Forecast

Average 62.71 USD  85.59%

High 75 USD

Low 46 USD

Based on 8 Wall Street analysts offering 12 month price targets forEnovis Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.